Which term best matches the description "Therapeutic evaluation of chemically equivalent drugs"?

• A. Black Box Warning
• B. Bioequivalence
• C. Ampule
• D. Assay

Answer: (B)

Bioequivalence is the concept behind the therapeutic evaluation of chemically equivalent drugs. When two formulations share the same active ingredient and strength and dosage form, bioequivalence asks whether they reach similar blood levels in the same amount of time. This focuses on the rate and extent of absorption, expressed mainly by the pharmacokinetic measures AUC (extent of exposure) and Cmax (peak concentration), with Tmax describing how quickly the peak is reached. If the two products produce comparable AUC and Cmax within predefined acceptance ranges (commonly 80–125% for the ratio of the test to reference product, with appropriate confidence intervals), they are considered bioequivalent and expected to have the same therapeutic effect and safety profile. This concept underpins the approval of generics, ensuring that they are therapeutically interchangeable with brand-name counterparts. The other options don’t describe this interchangeability concept: a black box warning relates to safety labeling, an ampule is just packaging, and an assay is a lab test for potency, not a comparison of blood level profiles.